Skip to main content

NHMRC-CIHR Canadian Consortium on Neurodegeneration in Aging (CCNA): Indigenous Health Research

Funding Providers

National Health and Medical Research Council (NHMRC)

Location

Australia Wide

Funding Type

Research R00075

Primary Category

Research

Eligible to

  • Not-for-Profits
  • Universities
  • Businesses

Funding

Amount (max): $3,000,000

Round(s)

  • Opened 22-Aug-2024 Closes 05-Feb-2025

Purpose

NHMRC will support up to 2 Canadian-Australian collaborative teams undertaking research that advances the field of research in any of the recognised forms of dementia, specifically in Indigenous populations

Overview

The research should focus on either:

  • The development, implementation, evaluation and/or scaling of Indigenous-led, and/or culturally appropriate and Indigenous-grounded approaches to risk reduction, early detection, diagnosis and assessment of age-related neurodegenerative diseases; and/or
  • The development, implementation, evaluation and/or scaling of Indigenous-led, and/or culturally appropriate and Indigenous-grounded approaches to different models of care for age-related neurodegenerative diseases in Indigenous Peoples and communities.

This grant opportunity will support projects relevant to its specific objectives in the 3 CCNA research thematic areas. All applications are required to identify the research theme(s) relevant to their proposal to be considered for funding:

  • Theme 1: Primary Prevention - Aimed at preventing disease from occurring, through the identification of mechanisms and/or conditions responsible for the neurodegenerative processes that lead to Alzheimer’s Disease and related dementias.
  • Theme 2: Secondary Prevention and Treatment - Focused on delaying or slowing the clinical manifestations or progression of the already developing disease through better understanding of mechanisms, diagnosis and early intervention. 
  • Theme 3: Quality of Life - Designed for helping individuals, care partners and the health system to cope with clinically manifested disease, by improving quality of life, improving access to quality care and enabling the healthcare system to increase efficiencies in dementia care.

Applications / Guidelines

Contact Details

We take pride in ensuring our data is up to date and accurate, but you should not rely on our data alone. Please double-check important information on the funder's website before applying.